Women's Health Innovation Summit USA
When:
Monday, Sep 23, 2024 9:00a -
Wednesday, Sep 25, 2024 5:15p
Monday, Sep 23, 2024 9:00a -
Wednesday, Sep 25, 2024 5:15p
Where:
Sheraton Boston Hotel
39 Dalton Street
Boston, Massachusetts 02199
Admission:
$599.00 - $24999.00
Hosted by:
Event website:
https://go.evvnt.com/2369683-0?pid=5248
The Women's Health Innovation Summit builds the roadmap to success by uniting the entire ecosystem of stakeholders and key opinion leaders to facilitate connections, share cutting-edge knowledge, and provide a platform for deep market expertise to flourish. Our purpose is simple: to take women's health to the next level.
Our agenda is created to maximize opportunities to meet new partners at the event and to showcase the most exciting startups in the space.
Women's health is no longer just a mission, it's a business opportunity. Explore the WHIS experience to find out how we bring the community together to facilitate growth.
URL:
LinkedIn: https://go.evvnt.com/2369683-2?pid=5248
Prices:
NPO/ CHARITY/ GOVERNMENT/ CLINICIAN RATE (early bird rate until May 24): USD 599.00,
EMERGING/START-UPS RATE (early bird rate until May 24): USD 799.00,
INDUSTRY RATE (early bird rate until May 24): USD 1799.00,
SERVICE PROVIDERS AND BIG PHARMA RATE (early bird rate until May 24): USD 2499.00,
NPO/ CHARITY/ GOVERNMENT/ CLINICIAN RATE (standard rate): USD 999.00,
EMERGING/START-UPS RATE (standard rate): USD 1399.00,
INDUSTRY RATE (standard rate): USD 24999.00,
SERVICE PROVIDERS AND BIG PHARMA RATE (standard rate): USD 3299.00
Speakers: Nichole Young Lin MD, MBA, Women's Health Clinical Lead, Google, Patricia Obermaier, Chief Growth Officer, Global Health and Life Sciences, Microsoft, Hadine Joffee, Director of Women's Hormone and Aging Research, Brigham and Women's Hospital, Monica Garcia, Assistant Director, Obstetrical and Reproductive Health Devices Team, CDRH, FDA, Shefali Goyal PharmD, VP, Head of Global Product Regulatory Strategy, and US Regulatory Affairs, Organon, Trish Costello, Founder and CEO, Portfolia, Jennifer Schneiders, President Diagnostic Solutions, Hologic, Asima Ahmad, Co-Founder and Chief Medical Officer, Carrot Fertility, Dr. Neel Shah, Chief Medical Officer, Maven Clinic, Carolee Lee, Founder and CEO, WHAM (Women's Health Access Matters), Elizabeth Cherot MD, MBA, Chief Medical Officer, March of Dimes, Jason Roberts, Gynecological and Surgical Devices, CDRH, FDA, Michael Annichine, CEO, Magee-Womens Research Institute, Alice Zheng, MD, MBA, MPH, Principal, RH Capital, Diana Torgersen, Executive Director, External Innovation and Emerging Science, Organon, Lisa Suennen, Managing Partner, AHA Ventures, American Heart Association, Daniel Johnston, Chief, Contraception Research Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Laura Clark-Kelly, Senior Director of Value and Reimbursement, Harmony Biosciences, Greg Singleton, Chief Artificial Intelligence Officer, US Department of Health and Human Services, Piraye Beim, Founder and CEO, Celmatix, Everett Handford, MBA, Regional Director, New England, US Department of Health Human Services, Natalie Buford-Young, CEO, Springboard Enterprises, Nada Hanafi, Co-Founder, MedTech Color, Susan Nicholson MD, FIDSA, Board Member, ASPIVIX, Roslyn Holliday Moore, Deputy Director for Programs Office of Behavioral Equity, US Department of Health and Human Services, Jasmi Shah, Managing Director, Cigna Ventures, Jacqueline Oliveira-Cella, Founder, wellBe Consulting, Lisa Marceau, Co-Founder, Joyuus, Ariel Kramer, President and Founder, Klover Communications, Valerie Palmieri, CEO, MOMENTUM Consulting, Rachel Braun Scherl, Business Builder, Marketing Strategist, Vagipreneur, SPARK Solutions for Growth, Maryon Stewart BEM, CEO and Founder, Femmar Health, Ivana Munci-Vasic, CEO and Founder, Vitra Labs, Erkeda DeRouen, CEO and Principal Consultant, Digital Risk Compliance Solutions, Brianna Brennan, Chief Innovation Officer, Ontrak Health, Claire Gill, CEO, Bone Health and Osteoporosis Foundation, Emilė Radyte, Co-Founder and CEO, Samphire Neuroscience, Mira Kaufman, Investment Team, Ingeborg Investment, Rachel Robinson, Chief Operating Officer, MassMedic
Category: Conferences | Health
